Travere Therapeutics names new R&D head ahead of 2027 retirement
Go back to Travere Therapeutics names new R&D head ahead of 2027 retirement| (NASDAQ: TVTX) | Delayed: 56.68 +0.42 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.26 | 52 Week High | $ | |||
| Open | $54.80 | 52 Week Low | $ | |||
| Day High | $60.00 | P/E | N/A | |||
| Day Low | $54.32 | EPS | $ | |||
| Volume | 1,369,313 | |||||

